The CR rate of induce chemotherapy of the patients with AML with multilineage dysplasia following MDS were significantly lower than other patients (P< 0.05).
有多系增生异常患者的诱导化疗CR率明显低于无多系增生异常患者（P<0.05）。
The CR rate of induce chemotherapy of the patients with AML with multilineage dysplasia following MDS were significantly lower than other patients (P< 0.05).
有多系增生异常患者的诱导化疗CR率明显低于无多系增生异常患者（P<0.05）。
应用推荐